2023
DOI: 10.1016/j.medcli.2023.01.024
|View full text |Cite
|
Sign up to set email alerts
|

Lung ultrasound score severity cut-off points in COVID-19 pneumonia. A systematic review and validating cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…A study by Bardakci et al documented the sensitivity and specificity rates as 90.3% and 60.4%, respectively, with a cut‐off value of >11 20 . Yet another study observed that sensitivity and specificity rates of 74% and 56%, respectively, were an indicator of mortality in patients with a cut‐off value of >15 21 . Only patients with COVID‐19 pneumonia were included in these studies, and our study includes all patients diagnosed with ARDS, regardless of the causative agent.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A study by Bardakci et al documented the sensitivity and specificity rates as 90.3% and 60.4%, respectively, with a cut‐off value of >11 20 . Yet another study observed that sensitivity and specificity rates of 74% and 56%, respectively, were an indicator of mortality in patients with a cut‐off value of >15 21 . Only patients with COVID‐19 pneumonia were included in these studies, and our study includes all patients diagnosed with ARDS, regardless of the causative agent.…”
Section: Discussionmentioning
confidence: 99%
“…20 Yet another study observed that sensitivity and specificity rates of 74% and 56%, respectively, were an indicator of mortality in patients with a cut-off value of >15. 21 Only patients with COVID-19 pneumonia were included in these studies, and our study includes all patients diagnosed with ARDS, regardless of the causative agent. In another research, the cut-off value was 18 and the sensitivity and specificity values were 77.04% and 61.29%, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…POCUS use has increased significantly during the pandemic for monitoring the inflammatory lung changes seen in COVID-19 patients [18][19][20][21][22][23][24]. This is facilitated in part by the typical sonographic characteristics of COVID-19-associated lung injury during disease progression and recovery [25][26][27][28][29][30][31][32][33][34][35][36][37]. Usually, POCUS is operated by experienced clinicians.…”
Section: The Role Of Pocus In the Management Of Covid-19 Patientsmentioning
confidence: 99%